Palomar Q2 Shows Modest Normalization, Surety Segment Debuts In Line

What happened

Palomar’s second-quarter results reflected the guided normalization, with the loss ratio settling just inside the mid-30s and the adjusted combined ratio holding near 75%, consistent with full-year targets. The newly formed Surety and Credit segment reported a loss ratio of 22%, a clean start that supports management’s ‘modestly accretive’ framing, though purchase accounting remains outstanding. Reinsurance renewal terms at the critical June 1 deadline were described as ‘at approved economics,’ offering relief but warranting scrutiny given persistent commercial earthquake rate pressure. The balance sheet’s new covenant-bearing facility remains undrawn, and leverage metrics show ample headroom, but the lack of finalized purchase accounting for Gray Surety keeps reported equity and earnings subject to later revision. Absent any reserve strengthening or adverse development flags, the quarter avoided the bear-case triggers but failed to deliver the upside surprise needed to break the stock out of its wait-and-see range.

Implication

For investors, the quarter largely validated the base case but did not derisk the thesis sufficiently to warrant adding at current levels. The surety segment’s initial loss ratio is encouraging, but one quarter of data is insufficient to assess ultimate accident-year performance, especially with purchase accounting still incomplete. Reinsurance renewal terms, while benign, must be monitored as commercial earthquake pricing continues to erode the legacy fleet’s margin headroom. The absence of covenant stress or reserve charges is a positive, but the leverage and rating sensitivity embedded in the new facility means that any future underwriting volatility could quickly tighten financial flexibility. With the stock trading near the ‘Wait’ zone ($121), investors should await further evidence of stable loss trends and finalization of the Gray Surety accounting before considering an entry, as the risk-reward remains balanced.

Thesis delta

The thesis remains unchanged: Palomar is a disciplined specialty underwriter navigating a delicate mix shift, and Q2 evidence mildly supports the base case. However, the outstanding purchase accounting and the seasonal concentration of EQ risk in the second half keep the uncertainty elevated, so the ‘Wait’ rating is maintained with no shift in conviction or price targets.